01 1McNeil Consumer Healthcare
02 1McNeil Consumer Healthcare, division of Johnson & Johnson Inc.
03 1McNeil Consumer Products Company
01 22029015
02 12096575
01 3Loperamide HCI | Simethicone
01 1Caplet
02 2Chewable Tablet
01 22010-10-31
02 12013-05-19
Patent Expiration Date : 2010-10-31
Date Granted : 1996-02-20
Loperamide Hydrochloride, Simethicone
Brand Name : IMODIUM* ADVANCED MULTI-SYMPTOM
Patent Number : 2029015
Filing Date : 1990-10-31
Strength per Unit : loperamide HCl 2mg + simethicone 125mg
Dosage Form : Chewable Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2010-10-31
Date Granted : 1996-02-20
Patent Expiration Date : 2013-05-19
Date Granted : 2003-05-13
Loperamide Hydrochloride, Simethicone
Brand Name : IMODIUM* ADVANCED MULTI-SYMPTOM
Patent Number : 2096575
Filing Date : 1993-05-19
Strength per Unit : loperamide HCl 2mg + simethicone 125mg
Dosage Form : Chewable Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2013-05-19
Date Granted : 2003-05-13
Patent Expiration Date : 2010-10-31
Date Granted : 1996-02-20
Loperamide Hydrochloride, Simethicone
Brand Name : IMODIUM* ADVANCED CAPLET
Patent Number : 2029015
Filing Date : 1990-10-31
Strength per Unit : 2mg/125mg
Dosage Form : Caplet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2010-10-31
Date Granted : 1996-02-20
